Parabolic Drugs Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 13,083,333 (49%) | — | ₹11,121 Cr |
| NII (HNI) | — | 3,925,000 (15%) | — | ₹3,336 Cr |
| Retail | — | 9,158,334 (34%) | — | ₹7,785 Cr |
| Employee | — | 500,000 (2%) | — | ₹43 Cr |
| Σ Total | — | 26,666,667 (100%) | — | ₹226,667 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 80 | ₹6,800 |
| Retail (Max) | 13 | 1,040 | ₹88,400 |
| S-HNI (Min) | 14 | 1,120 | ₹95,200 |
| B-HNI (Min) | 67 | 5,360 | ₹455,600 |
Financial Statements Amount In Crore
| Metric | 30-Sept-09 | 31-Mar-09 | 31-Mar-08 |
|---|---|---|---|
| Revenue | 233 | 397 | 274 |
| Profit After Tax | 12 | 21 | 30 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Multi-purpose block III at Derabassi – 20.32
- 2 Sterile cephalosporin plant at Derabassi – 32.55
- 3 Establishment of Chachrauli plant – 16.03
- 4 Investment in our Subsidiary; – 46.62
- 5 Repayment / prepayment of identified loan facilities – 38.83
- 6 General corporate purposes – 17.59
Company Overview
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
Companies product portfolio comprises 42 APIs and 7 API intermediates which are marketed domestically and exported.
Company own and operate two manufacturing facilities at Derabassi, Punjab, and Panchkula, Haryana. Company is in the process of setting up a custom synthesis and research and development (R&D) center at Barwala, Haryana.